Our faculty member's areas of research are broad and include common allergic conditions, asthma, urticaria, autoimmunity and biotechnology, aspirin exacerbated respiratory disease, carmine allergy, atopic dermatitis, chronic sinusitis, and asthma outcomes. 

Several of our faculty conduct research at the University of Michigan Mary H. Weiser Food Allergy Center, where James R. Baker, Jr., MD, is the director. The Center's research is aimed at generating novel findings through basic and translational research that will provide future solutions for those with food allergies and can help lead to a cure for this condition.

We are a FARE (Food Allergy Research & Education) Clinical Network Center of Excellence, which is a nationwide network of leading research and clinical care facilities with a common goal of ensuring that patients with food allergies have access to state-of-the-art diagnosis, treatments, and research. 

Research Highlights

COVID-19 Antibodies Persist, Reduce Reinfection Risk for Up to Six Months, Study Finds

Charles Schuler, MD and team find that most patients with mild COVID-19 infections produce antibodies that persist and protect them from reinfection for up to six months.

Current Clinical Trials

Faculty Publications